عاشق تركيا
Contributing member
- Joined
- Nov 25, 2025
- Messages
- 98
- Reaction score
- 0
- Points
- 6
On 4 November 2026, Türkiye’s Social Security Institution announced changes to the lists governing reimbursement for medicines and certain medical nutrition products. Its official notice gives 6 November as the general effective date. Adding a pack, amending a record and passivating a record are different actions; a headline alone cannot determine an individual prescription’s coverage.
Checking your medicine: The product examples and counts below are based on published reports about the list. Ask a pharmacist to match the exact name, strength, pack and barcode against the latest list and check your reimbursement conditions.
| Category | Meaning | What to check |
|---|---|---|
| Additions | Product records added to the reimbursement list | Pack, strength, prescription and conditions |
| Amended records | Changes to existing product data | Specific row and barcode |
| Passivated records | Status changed for particular records | Do not generalise to every similar product |
| Medical nutrition | A change to the list for specified conditions | Product, row date and medical report |
Reports identify two additions: Thermonidyn gel 1% + 0.025%, and Votryxe 75 microgram tablets, pack of 50. They also report ten amended records and three passivated infusion records. These names identify packs; they are neither treatment recommendations nor proof of individual entitlement.
The reported passivations concern specific records for 500 ml isotonic sodium chloride without an administration set and 1,000 ml lactated Ringer with and without a set. They do not establish that every similar infusion was passivated or withdrawn from the market. Reports also identify an amendment to Renastep in the medical nutrition list, with a special row date of 4 November; verify the scope in the specific record.
Listing does not make a medicine free for every patient or appropriate for every condition. Reimbursement depends on actual insurance rights, the product, strength and pack, prescription and diagnosis, any required medical report, and the rules on the dispensing date. A contribution or price difference may apply. The final amount cannot be calculated from a product name alone.
An amended record does not by itself prove a change in composition, dose or personal entitlement. Ask a pharmacist to check the current barcode and identify whether the change concerns administrative details or reimbursement conditions.
1. Have the full product name, strength, form, pack size and barcode ready, along with the prescription and required report.
2. Check general health entitlement through the e-Devlet health entitlement service. General entitlement alone does not guarantee reimbursement for every prescription.
3. Ask a contracted pharmacy to check the current record, effective date and conditions for your case.
4. Request an itemised amount, including contributions or price differences, and ask about an equivalent alternative where the rules and clinician permit.
5. If the result remains unclear, contact the institution or clinician. Do not stop treatment or change dose based on a news item or general list.
Is this a general medicine price cut? The notice does not establish that; it concerns specified reimbursement records.
Does passivation mean a medicine is banned? Not necessarily. Reimbursement status differs from marketing authorisation and availability.
Does private insurance automatically qualify? No. Check the actual policy and entitlement.
Does every spreadsheet date mean reimbursement starts that day? No. It may refer to an earlier entry, activation, passivation or another procedure; check the column and row.
Related topics
October social security medicine updates
YUPASS and care under social security agreements
SGK services on e-Devlet
SGK for employees and family coverage
Registering a foreign worker with SGK
Using SGK and healthcare costs
Health insurance for residence permits
Work injuries and social security rights
Sick leave and SGK benefits